Fintel reports that on March 12, 2025, B. Riley Securities initiated coverage of Radiopharm Theranostics Limited - Depositary Receipt () (NasdaqCM:RADX) with a Buy recommendation. What are Other ...

B. Riley sees mixed Q4 results but gains aftermarket interest. Despite mild improvements, my long-term view on RILY stock is ...

Shares of B. Riley Financial were recently down 2.7%, to $4.34. The stock has fallen about 6% this year and 78% over the past 52 weeks.

B. Riley Financial (RILY) earlier today announced that a formerly wholly-owned subsidiary of the company has merged with Cascadia Investments ...

B. Riley Financial, Inc.’s RILY share price has dipped by 10.10%, which has investors questioning if this is right time to ...

Tripadvisor (NASDAQ:TRIP – Get Free Report) had its price objective reduced by research analysts at B. Riley from $20.00 to ...

B. Riley Financial (RILY) shares gapped up 10% in Monday after-hours trading after the financial services platform estimated ...

B. Riley analyst Mayank Mamtani reiterates a Buy rating on Viking Therapeutics (VKTX) with a $96 price target after the company announced a ...

Stock analysts at B. Riley increased their Q1 2025 earnings estimates for Identiv in a research note issued to investors on ...

On Feb. 27, B. Riley disclosed a new $160 million debt package provided by Oaktree Capital Management, and it used ...

Shares of the investment bank B. Riley Financial (NASDAQ: RILY) had exploded nearly 19% higher at 10:30 a.m. ET today after the company announced that it had secured new debt financing. It's been a ...